Items where Author is "Schlienger, R."

2016

Afonso, A. and Schmiedl, S. and Becker, C. and Tcherny-Lessenot, S. and Primatesta, P. and Plana, E. and Souverein, P. and Wang, Y. and Korevaar, J. C. and Hasford, J. and Reynolds, R. and de Groot, M. C. H. and Schlienger, R. and Klungel, O. and Rottenkolber, M.. (2016) A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction. European Journal of Clinical Pharmacology, 72 (9). pp. 1105-1116.

2014

Requena, G. and Abbing-Karahagopian, V. and Huerta, C. and De Bruin, M. L. and Alvarez, Y. and Miret, M. and Hesse, U. and Gardarsdottir, H. and Souverein, P. C. and Slattery, J. and Schneider, C. and Rottenkolber, M. and Schmiedl, S. and Gil, M. and De Groot, M. C. H. and Bate, A. and Ruigómez, A. and García Rodríguez, L. A. and Johansson, S. and de Vries, F. and Montero, D. and Schlienger, R. and Reynolds, R. and Klungel, O. H. and de Abajo, F. J.. (2014) Incidence rates and trends of hip/femur fractures in five European countries: comparison using e-healthcare records databases. Calcified tissue international, 94 (6). pp. 580-589.

2010

Kabanywanyi, A. M. and Lengeler, C. and Kasim, P. and King'eng'ena S., and Schlienger, R. and Mulure, N. and Genton, B.. (2010) Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania. Malaria Journal, Vol. 9 , 48.

Kabanywanyi, A. M. and Mulure, N. and Migoha, C. and Malila, A. and Lengeler, C. and Schlienger, R. and Genton, B.. (2010) Experience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting. Malaria Journal, Vol. 9 , 205.